Lazard Ltd:企業の戦略・SWOT・財務分析

◆英語タイトル:Lazard Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3541
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:バミューダ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Lazard Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Lazard Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Lazard Ltd (Lazard) offers asset management and financial advisory services. Its asset management business comprises global investment solutions and investment management services. The company offers investments in mutual funds, closed-end funds and retirement plans through multi-asset, global equity, US equity, emerging markets, fixed income, real assets, and alternative investments. It offers financial advisory services on mergers and acquisitions, strategic matters, middle markets, restructuring, capital markets, capital structure, and private capital to corporate leaders and governments. Lazard also offers funding to high quality middle market companies. The company has presence in Europe, Asia, North America, the Middle East, Central and South America and Australia. Lazard is headquartered in Hamilton, Bermuda.

Scope

- Detailed information on Lazard Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Lazard Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Lazard Ltd including a breakdown and examination of key business segments
- Intelligence on Lazard Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Lazard Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Lazard Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Lazard Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Lazard Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Lazard Ltd: Company Overview
Lazard Ltd: Overview and Key Facts
Lazard Ltd: Overview
Lazard Ltd: Key Facts
Lazard Ltd: Key Employees
Lazard Ltd: Key Employee Biographies
Lazard Ltd: Major Products and Services
Lazard Ltd: Company History
Lazard Ltd: Management Statement
Lazard Ltd: Locations and Subsidiaries
Lazard Ltd: Key Competitors
Lazard Ltd: Company Analysis
Lazard Ltd: Business Description
Lazard Ltd: SWOT Analysis
Lazard Ltd: SWOT Overview
Lazard Ltd: Strengths
Lazard Ltd: Weaknesses
Lazard Ltd: Opportunities
Lazard Ltd: Threats
Lazard Ltd: Corporate Financial Deals Activity
Lazard Ltd: Financial Deals Overview
Lazard Ltd: Targets and Partners
Lazard Ltd: Top Deals 2015 – 2019YTD*
Lazard Ltd: Mergers and Acquisitions
Lazard Ltd: Recent Developments
Lazard Ltd: News and Events Summary
Lazard Ltd: Business Expansion
Lazard Ltd: Contracts
Lazard Ltd: Corporate Governance
Lazard Ltd: Financial Performance
Lazard Ltd: Red Flags/DistressSignals
Lazard Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Lazard Ltd: Key Facts
Table 2: Lazard Ltd: Key Employees
Table 3: Lazard Ltd: Company History
Table 4: Lazard Ltd: Locations and Subsidiaries
Table 5: Lazard Ltd: Key Competitors
Table 6: Lazard Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Lazard Ltd: Targets and Partners
Table 8: Lazard Ltd: Top Deals 2015 - 2019YTD*
Table 9: Lazard Ltd: M&A Volume and Value Trend (2015 - YTD*2019)
Table 10: Lazard Ltd: M&A Activity by Geography (2015 - YTD*2019)
Table 11: Lazard Ltd: News and Events Summary
Table 12: Lazard Ltd: Business Expansion
Table 13: Lazard Ltd: Contracts
Table 14: Lazard Ltd: Corporate Governance
Table 15: Lazard Ltd: Financial Performance
Table 16: Lazard Ltd: Red Flags/DistressSignals
Table 17: Lazard Ltd: Strategy and Operations

★海外企業調査レポート[Lazard Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • Absa Bank Ltd
    Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Absa Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The National Commercial Bank
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Spero Therapeutics Inc (SPRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Spero Therapeutics Inc. (Spero) is a clinical-stage biopharmaceutical company. It is engaged in developing, identifying and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections. Its product pipeline includes SPR994 oral gram-negative program, SPR741and SPR206 …
  • Allergan plc:企業の戦略・SWOT・財務情報
    Allergan plc - Strategy, SWOT and Corporate Finance Report Summary Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cracker Barrel Old Country Store, Inc.:企業の戦略・SWOT・財務分析
    Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cracker Barrel Old Country Store, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Arthrex Inc-医療機器分野:企業M&A・提携分析
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company which designs, and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and …
  • Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs a …
  • Luna Innovations Inc (LUNA)-医療機器分野:企業M&A・提携分析
    Summary Luna Innovations Inc (Luna) is a optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company’s products include fiber optic sensing products, fiber optic test and measurement products, high speed optical products, …
  • Linear Technology Corporation (LLTC):企業の戦略的SWOT分析
    Linear Technology Corporation (LLTC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析
    Summary Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform techno …
  • Taconic Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Taconic Biosciences Inc (Taconic), formerly Taconic Farms Inc is a research model provider that offers animal health models and laboratory services. The company’s products include taconic transgenic mouse models, emerging models, cryopreserved models, traditional models, diet induced obese, …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Daito Trust Construction Co., Ltd.
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Leukemia & Lymphoma Society Inc-製薬・医療分野:企業M&A・提携分析
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a health organization that offers funding research, finding cures and access to treatments for blood cancer patients. The organization’s services include patient support, health education, policy advocacy, funds raising and medical research fundin …
  • Investor AB (INVE B):企業の財務・戦略的SWOT分析
    Investor AB (INVE B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆